Baseline features of patients according to the presence of HBV reactivation. HBV, hepatitis B virus; HCV, hepatitis C virus; HCC, hepatocellular carcinoma; DAA, direct acting antiviral agents; DCV, daclatasvir; ASV, asunaprevir; SOF, sofosbuvir; RBV, ribavirin; OPr-D, ombitavir/paritaprevir/ritonavir plus dasabuvir; G/P, glecaprevir/pibrentasvir; LDV, ledipasvir; SVR, sustained virological response; IFN, interferon; DAA, direct acting antiviral.
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://figshare.com/articles/dataset/Baseline_features_of_patients_according_to_the_presence_of_HBV_reactivation_HBV_hepatitis_B_virus_HCV_hepatitis_C_virus_HCC_hepatocellular_carcinoma_DAA_direct_acting_antiviral_agents_DCV_daclatasvir_ASV_asunaprevir_SOF_sofosbuvir_RBV_ribav/29199956
下载链接
链接失效反馈官方服务：
资源简介：
Baseline features of patients according to the presence of HBV reactivation. HBV, hepatitis B virus; HCV, hepatitis C virus; HCC, hepatocellular carcinoma; DAA, direct acting antiviral agents; DCV, daclatasvir; ASV, asunaprevir; SOF, sofosbuvir; RBV, ribavirin; OPr-D, ombitavir/paritaprevir/ritonavir plus dasabuvir; G/P, glecaprevir/pibrentasvir; LDV, ledipasvir; SVR, sustained virological response; IFN, interferon; DAA, direct acting antiviral.
创建时间：
2025-05-30
